Loading…

The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics

The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of food quality 2020, Vol.2020 (2020), p.1-11
Main Authors: Khurshid, Mohsin, Rajoka, Muhammad Shahid Riaz, Raza, Hammad, Rasool, Maria, Ashfaq, Usman Ali, Munir, Samman, Almatroudi, Ahmad, Afzal, Muhammad, Mazhar, Sayyeda Farwa, Munir, Hafiz Muhammad Waqas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3
cites cdi_FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3
container_end_page 11
container_issue 2020
container_start_page 1
container_title Journal of food quality
container_volume 2020
creator Khurshid, Mohsin
Rajoka, Muhammad Shahid Riaz
Raza, Hammad
Rasool, Maria
Ashfaq, Usman Ali
Munir, Samman
Almatroudi, Ahmad
Afzal, Muhammad
Mazhar, Sayyeda Farwa
Munir, Hafiz Muhammad Waqas
description The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical trials. Consequently, the notion got a considerable interest in those strains having proven probiotic potential to be engineered for improvement in their beneficial features. The process of genetic engineering can also be used for probiotic strains for the reversion of antimicrobial resistance and other modifications for their safer and effective human applications. The lactic acid bacilli are predominantly opposite as they already have gained attention owing to their health-promoting benefits and their safety for human consumption; therefore, their use, especially as a delivery agent of vaccines and drugs, is gaining attention. The tailoring of probiotic strains will not only improve the data regarding the probiotic potential of these strains but also clinch the doubts concerning these probiotics. This article focuses on the approaches of bioengineered probiotics and discusses the potential prospects for their therapeutic applications including immunomodulation, cognitive health, and anticancer therapeutics.
doi_str_mv 10.1155/2020/9676452
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_aaa7eaf94e784fafb7acf9128c3ce7c1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A624611182</galeid><doaj_id>oai_doaj_org_article_aaa7eaf94e784fafb7acf9128c3ce7c1</doaj_id><sourcerecordid>A624611182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3</originalsourceid><addsrcrecordid>eNqFkc1rFEEQxQdRcI3ePMuAR52kP6enjyHEuBBQMJ6bmprqTS-z02P3LJL_3l4nGARB-tDw6lePqnpV9Zazc861vhBMsAvbmlZp8azacKN0o7Q2z6sN46ptrBLdy-pVznvGpNZMbapvd_dUf00xz4RLrn1M9VKUoiaY6bgErLeHeQwIS4hTrqOvb2iiosM4PtTX0y5MRImGk0kfYink19ULD2OmN4__WfX90_Xd1efm9svN9urytkFl5dLwHmngHMn3WlqDFntUnrhhUkreadkzP6gOO4ZDKwCFEVq2nAmrEAYEeVZtV98hwt7NKRwgPbgIwf0WYto5SGWgkRwAGAJvFZlOefC9AfSWiw4lkkFevN6vXnOKP46UF7ePxzSV8Z2QlndWtqx9onZQTMPk45IADyGju2yFajnnnSjU-T-o8gY6BIwT-VD0vxo-rg1YgsiJ_J9lOHOnZN0pWfeYbME_rPh9mAb4Gf5Hv1tpKgx5eKLLjZnq5C_JM6vq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2391893606</pqid></control><display><type>article</type><title>The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics</title><source>Business Source Ultimate</source><source>Publicly Available Content Database</source><source>Wiley-Blackwell Open Access Titles(OpenAccess)</source><creator>Khurshid, Mohsin ; Rajoka, Muhammad Shahid Riaz ; Raza, Hammad ; Rasool, Maria ; Ashfaq, Usman Ali ; Munir, Samman ; Almatroudi, Ahmad ; Afzal, Muhammad ; Mazhar, Sayyeda Farwa ; Munir, Hafiz Muhammad Waqas</creator><contributor>Giaouris, Efstathios ; Efstathios Giaouris</contributor><creatorcontrib>Khurshid, Mohsin ; Rajoka, Muhammad Shahid Riaz ; Raza, Hammad ; Rasool, Maria ; Ashfaq, Usman Ali ; Munir, Samman ; Almatroudi, Ahmad ; Afzal, Muhammad ; Mazhar, Sayyeda Farwa ; Munir, Hafiz Muhammad Waqas ; Giaouris, Efstathios ; Efstathios Giaouris</creatorcontrib><description>The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical trials. Consequently, the notion got a considerable interest in those strains having proven probiotic potential to be engineered for improvement in their beneficial features. The process of genetic engineering can also be used for probiotic strains for the reversion of antimicrobial resistance and other modifications for their safer and effective human applications. The lactic acid bacilli are predominantly opposite as they already have gained attention owing to their health-promoting benefits and their safety for human consumption; therefore, their use, especially as a delivery agent of vaccines and drugs, is gaining attention. The tailoring of probiotic strains will not only improve the data regarding the probiotic potential of these strains but also clinch the doubts concerning these probiotics. This article focuses on the approaches of bioengineered probiotics and discusses the potential prospects for their therapeutic applications including immunomodulation, cognitive health, and anticancer therapeutics.</description><identifier>ISSN: 0146-9428</identifier><identifier>EISSN: 1745-4557</identifier><identifier>DOI: 10.1155/2020/9676452</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Acids ; Antibiotics ; B cells ; Bacteria ; Design ; Drug resistance in microorganisms ; E coli ; Food ; Food quality ; Genetic engineering ; Genetically modified organisms ; Health aspects ; Infections ; Microorganisms ; Pathogens ; Probiotics</subject><ispartof>Journal of food quality, 2020, Vol.2020 (2020), p.1-11</ispartof><rights>Copyright © 2020 Sayyeda Farwa Mazhar et al.</rights><rights>COPYRIGHT 2020 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2020 Sayyeda Farwa Mazhar et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3</citedby><cites>FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3</cites><orcidid>0000-0002-3196-2857 ; 0000-0002-1491-6402</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2391893606/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2391893606?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,4024,25753,27923,27924,27925,37012,44590,75126</link.rule.ids></links><search><contributor>Giaouris, Efstathios</contributor><contributor>Efstathios Giaouris</contributor><creatorcontrib>Khurshid, Mohsin</creatorcontrib><creatorcontrib>Rajoka, Muhammad Shahid Riaz</creatorcontrib><creatorcontrib>Raza, Hammad</creatorcontrib><creatorcontrib>Rasool, Maria</creatorcontrib><creatorcontrib>Ashfaq, Usman Ali</creatorcontrib><creatorcontrib>Munir, Samman</creatorcontrib><creatorcontrib>Almatroudi, Ahmad</creatorcontrib><creatorcontrib>Afzal, Muhammad</creatorcontrib><creatorcontrib>Mazhar, Sayyeda Farwa</creatorcontrib><creatorcontrib>Munir, Hafiz Muhammad Waqas</creatorcontrib><title>The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics</title><title>Journal of food quality</title><description>The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical trials. Consequently, the notion got a considerable interest in those strains having proven probiotic potential to be engineered for improvement in their beneficial features. The process of genetic engineering can also be used for probiotic strains for the reversion of antimicrobial resistance and other modifications for their safer and effective human applications. The lactic acid bacilli are predominantly opposite as they already have gained attention owing to their health-promoting benefits and their safety for human consumption; therefore, their use, especially as a delivery agent of vaccines and drugs, is gaining attention. The tailoring of probiotic strains will not only improve the data regarding the probiotic potential of these strains but also clinch the doubts concerning these probiotics. This article focuses on the approaches of bioengineered probiotics and discusses the potential prospects for their therapeutic applications including immunomodulation, cognitive health, and anticancer therapeutics.</description><subject>Acids</subject><subject>Antibiotics</subject><subject>B cells</subject><subject>Bacteria</subject><subject>Design</subject><subject>Drug resistance in microorganisms</subject><subject>E coli</subject><subject>Food</subject><subject>Food quality</subject><subject>Genetic engineering</subject><subject>Genetically modified organisms</subject><subject>Health aspects</subject><subject>Infections</subject><subject>Microorganisms</subject><subject>Pathogens</subject><subject>Probiotics</subject><issn>0146-9428</issn><issn>1745-4557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkc1rFEEQxQdRcI3ePMuAR52kP6enjyHEuBBQMJ6bmprqTS-z02P3LJL_3l4nGARB-tDw6lePqnpV9Zazc861vhBMsAvbmlZp8azacKN0o7Q2z6sN46ptrBLdy-pVznvGpNZMbapvd_dUf00xz4RLrn1M9VKUoiaY6bgErLeHeQwIS4hTrqOvb2iiosM4PtTX0y5MRImGk0kfYink19ULD2OmN4__WfX90_Xd1efm9svN9urytkFl5dLwHmngHMn3WlqDFntUnrhhUkreadkzP6gOO4ZDKwCFEVq2nAmrEAYEeVZtV98hwt7NKRwgPbgIwf0WYto5SGWgkRwAGAJvFZlOefC9AfSWiw4lkkFevN6vXnOKP46UF7ePxzSV8Z2QlndWtqx9onZQTMPk45IADyGju2yFajnnnSjU-T-o8gY6BIwT-VD0vxo-rg1YgsiJ_J9lOHOnZN0pWfeYbME_rPh9mAb4Gf5Hv1tpKgx5eKLLjZnq5C_JM6vq</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Khurshid, Mohsin</creator><creator>Rajoka, Muhammad Shahid Riaz</creator><creator>Raza, Hammad</creator><creator>Rasool, Maria</creator><creator>Ashfaq, Usman Ali</creator><creator>Munir, Samman</creator><creator>Almatroudi, Ahmad</creator><creator>Afzal, Muhammad</creator><creator>Mazhar, Sayyeda Farwa</creator><creator>Munir, Hafiz Muhammad Waqas</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><general>Hindawi-Wiley</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8C1</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3196-2857</orcidid><orcidid>https://orcid.org/0000-0002-1491-6402</orcidid></search><sort><creationdate>2020</creationdate><title>The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics</title><author>Khurshid, Mohsin ; Rajoka, Muhammad Shahid Riaz ; Raza, Hammad ; Rasool, Maria ; Ashfaq, Usman Ali ; Munir, Samman ; Almatroudi, Ahmad ; Afzal, Muhammad ; Mazhar, Sayyeda Farwa ; Munir, Hafiz Muhammad Waqas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acids</topic><topic>Antibiotics</topic><topic>B cells</topic><topic>Bacteria</topic><topic>Design</topic><topic>Drug resistance in microorganisms</topic><topic>E coli</topic><topic>Food</topic><topic>Food quality</topic><topic>Genetic engineering</topic><topic>Genetically modified organisms</topic><topic>Health aspects</topic><topic>Infections</topic><topic>Microorganisms</topic><topic>Pathogens</topic><topic>Probiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khurshid, Mohsin</creatorcontrib><creatorcontrib>Rajoka, Muhammad Shahid Riaz</creatorcontrib><creatorcontrib>Raza, Hammad</creatorcontrib><creatorcontrib>Rasool, Maria</creatorcontrib><creatorcontrib>Ashfaq, Usman Ali</creatorcontrib><creatorcontrib>Munir, Samman</creatorcontrib><creatorcontrib>Almatroudi, Ahmad</creatorcontrib><creatorcontrib>Afzal, Muhammad</creatorcontrib><creatorcontrib>Mazhar, Sayyeda Farwa</creatorcontrib><creatorcontrib>Munir, Hafiz Muhammad Waqas</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><collection>Public Health Database</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of food quality</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khurshid, Mohsin</au><au>Rajoka, Muhammad Shahid Riaz</au><au>Raza, Hammad</au><au>Rasool, Maria</au><au>Ashfaq, Usman Ali</au><au>Munir, Samman</au><au>Almatroudi, Ahmad</au><au>Afzal, Muhammad</au><au>Mazhar, Sayyeda Farwa</au><au>Munir, Hafiz Muhammad Waqas</au><au>Giaouris, Efstathios</au><au>Efstathios Giaouris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics</atitle><jtitle>Journal of food quality</jtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>0146-9428</issn><eissn>1745-4557</eissn><abstract>The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical trials. Consequently, the notion got a considerable interest in those strains having proven probiotic potential to be engineered for improvement in their beneficial features. The process of genetic engineering can also be used for probiotic strains for the reversion of antimicrobial resistance and other modifications for their safer and effective human applications. The lactic acid bacilli are predominantly opposite as they already have gained attention owing to their health-promoting benefits and their safety for human consumption; therefore, their use, especially as a delivery agent of vaccines and drugs, is gaining attention. The tailoring of probiotic strains will not only improve the data regarding the probiotic potential of these strains but also clinch the doubts concerning these probiotics. This article focuses on the approaches of bioengineered probiotics and discusses the potential prospects for their therapeutic applications including immunomodulation, cognitive health, and anticancer therapeutics.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><doi>10.1155/2020/9676452</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-3196-2857</orcidid><orcidid>https://orcid.org/0000-0002-1491-6402</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-9428
ispartof Journal of food quality, 2020, Vol.2020 (2020), p.1-11
issn 0146-9428
1745-4557
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_aaa7eaf94e784fafb7acf9128c3ce7c1
source Business Source Ultimate; Publicly Available Content Database; Wiley-Blackwell Open Access Titles(OpenAccess)
subjects Acids
Antibiotics
B cells
Bacteria
Design
Drug resistance in microorganisms
E coli
Food
Food quality
Genetic engineering
Genetically modified organisms
Health aspects
Infections
Microorganisms
Pathogens
Probiotics
title The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A59%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Prospects%20for%20the%20Therapeutic%20Implications%20of%20Genetically%20Engineered%20Probiotics&rft.jtitle=Journal%20of%20food%20quality&rft.au=Khurshid,%20Mohsin&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=0146-9428&rft.eissn=1745-4557&rft_id=info:doi/10.1155/2020/9676452&rft_dat=%3Cgale_doaj_%3EA624611182%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-1bced11cefb5397c9cbc4fe1703331853b0fd48c80cd62ac27253610294cadca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2391893606&rft_id=info:pmid/&rft_galeid=A624611182&rfr_iscdi=true